Gil Blum
Stock Analyst at Needham
(3.78)
# 732
Out of 5,124 analysts
423
Total ratings
40.15%
Success rate
11.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Maintains: Buy | $10 → $11 | $1.99 | +452.76% | 33 | Dec 29, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $80 | $52.44 | +52.56% | 27 | Dec 23, 2025 | |
| MREO Mereo BioPharma Group | Reiterates: Buy | $5 | $0.42 | +1,099.90% | 20 | Dec 22, 2025 | |
| ABSI Absci | Reiterates: Buy | $7 | $3.49 | +100.57% | 7 | Dec 12, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $26 | $18.97 | +37.06% | 28 | Dec 8, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $65.20 | +61.04% | 24 | Dec 8, 2025 | |
| SLDB Solid Biosciences | Initiates: Buy | $16 | $5.64 | +183.69% | 1 | Dec 4, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $9 → $6 | $1.00 | +500.00% | 8 | Nov 4, 2025 | |
| CELC Celcuity | Reiterates: Buy | $70 | $99.74 | -29.82% | 21 | Oct 20, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $10 | $5.50 | +81.82% | 31 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $4.29 | +319.58% | 7 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.09 | +95.60% | 25 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.85 | +440.54% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $21.52 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.51 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $7.21 | +454.79% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $34.60 | +105.20% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $3.65 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $14.19 | +238.27% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.32 | +354.55% | 23 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.24 | - | 8 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Buy | $15 | $5.68 | +164.08% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.98 | - | 9 | Oct 27, 2025 |
Autolus Therapeutics
Dec 29, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $1.99
Upside: +452.76%
CRISPR Therapeutics AG
Dec 23, 2025
Reiterates: Buy
Price Target: $80
Current: $52.44
Upside: +52.56%
Mereo BioPharma Group
Dec 22, 2025
Reiterates: Buy
Price Target: $5
Current: $0.42
Upside: +1,099.90%
Absci
Dec 12, 2025
Reiterates: Buy
Price Target: $7
Current: $3.49
Upside: +100.57%
Nurix Therapeutics
Dec 8, 2025
Reiterates: Buy
Price Target: $26
Current: $18.97
Upside: +37.06%
Arcellx
Dec 8, 2025
Reiterates: Buy
Price Target: $105
Current: $65.20
Upside: +61.04%
Solid Biosciences
Dec 4, 2025
Initiates: Buy
Price Target: $16
Current: $5.64
Upside: +183.69%
TScan Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $1.00
Upside: +500.00%
Celcuity
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $99.74
Upside: -29.82%
Taysha Gene Therapies
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $5.50
Upside: +81.82%
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $4.29
Upside: +319.58%
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $4.09
Upside: +95.60%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.85
Upside: +440.54%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $21.52
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.51
Upside: -
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $7.21
Upside: +454.79%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $34.60
Upside: +105.20%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.65
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $14.19
Upside: +238.27%
Jul 26, 2024
Reiterates: Buy
Price Target: $6
Current: $1.32
Upside: +354.55%
Dec 19, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.24
Upside: -
Nov 7, 2025
Suspends: Buy
Price Target: $15
Current: $5.68
Upside: +164.08%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.98
Upside: -